Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics.

Ghoussaini M. et al, (2021), Nucleic acids research, 49, D1311 - D1320

CD70 expression determines the therapeutic efficacy of expanded human regulatory T cells

Arroyo Hornero R. et al, (2020), Communications Biology, 3

Circulating C-peptide levels mirror patterns of residual beta cell mass in the pancreas of children and young people with type 1 diabetes

Carr ALJ. et al, (2020), DIABETOLOGIA, 63, S132 - S133

Publisher Correction: Whole-genome sequencing of a sporadic primary immunodeficiency cohort.

Thaventhiran JED. et al, (2020), Nature, 584

Whole-genome sequencing of a sporadic primary immunodeficiency cohort

Thaventhiran JED. et al, (2020), Nature, 583, 90 - 95

Whole-genome sequencing of patients with rare diseases in a national health system.

Turro E. et al, (2020), Nature, 583, 96 - 102

Author Correction: Approaches and advances in the genetic causes of autoimmune disease and their implications

Inshaw JRJ. et al, (2020), Nature Immunology

Interleukin-2 Therapy of Autoimmunity in Diabetes (ITAD): a phase 2, multicentre, double-blind, randomized, placebo-controlled trial

Marcovecchio ML. et al, (2020), Wellcome Open Research, 5, 49 - 49

Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol.

Boughton C. et al, (2020), BMJ open, 10

Genetic Variants Predisposing Most Strongly to Type 1 Diabetes Diagnosed Under Age 7 Years Lie Near Candidate Genes That Function in the Immune System and in Pancreatic β-Cells.

Inshaw JRJ. et al, (2020), Diabetes care, 43, 169 - 177

PRF1 mutation alters immune system activation, inflammation, and risk of autoimmunity

Sidore C. et al, (2020), Multiple Sclerosis Journal

Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp620 Risk Allele Drive the Expansion of FOXP3+ Regulatory T Cells and PD-1 Expression

Ferreira RC. et al, (2019), Frontiers in Immunology, 10

The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes.

Ramos-Rodríguez M. et al, (2019), Nature genetics, 51, 1588 - 1595

An integrated platform to systematically identify causal variants and genes for polygenic human traits

Downes DJ. et al, (2019)

A genome-wide search for genes affecting the age-at-diagnosis of type 1 diabetes

Syreeni A. et al, (2019), DIABETOLOGIA, 62, S108 - S108

Genetic association analysis of type 1 diabetes in > 60,000 ancestrally diverse subjects: refinement of existing association signals and discovery of novel type 1 diabetes risk loci

Rich SS. et al, (2019), DIABETOLOGIA, 62, S107 - S107

Identification of infants with increased type 1 diabetes genetic risk for enrollment into Primary Prevention Trials-GPPAD-02 study design and first results.

Winkler C. et al, (2019), Pediatric diabetes, 20, 720 - 727

Comparative performances of machine learning methods for classifying Crohn Disease patients using genome-wide genotyping data.

Romagnoni A. et al, (2019), Scientific reports, 9

Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol.

Ziegler A-G. et al, (2019), BMJ open, 9

Publisher Correction: Approaches and advances in the genetic causes of autoimmune disease and their implications

Inshaw JRJ. et al, (2019), Nature Immunology, 20, 375 - 375

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?